MSB 2.70% 95.0¢ mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-443

  1. 54 Posts.
    lightbulb Created with Sketch. 3
    Just my opinion, I believe the FDA rejected our application because we are not american. They want an american company to lead the world and they will all make a lot more money and sit on a lot of boards. I think you will see more obstacles in MSB paths for their other applications. This is not a level playing field. I raise this issue three months ago. The United States is corrupt and in decline.
    This is a volatile share and I think has a great future if it gets approved.
    I have sold down three quarters of my holding fortunately breaking square.
    Best wishes to all shareholders
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
0.025(2.70%)
Mkt cap ! $1.084B
Open High Low Value Volume
94.0¢ 96.8¢ 93.5¢ $4.207M 4.417M

Buyers (Bids)

No. Vol. Price($)
3 42268 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.0¢ 48002 3
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.